NeuroOne Medical Technologies Corp Stock

$0.87

1.88% today

Nasdaq, Jul 28, 04:53 pm CET

ISIN

US64130M2098

Symbol

NMTC

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Overview Dividends Analysts Charts News Strategies

NeuroOne Medical Technologies Corp Stock price

$0.89

-4.06 82.09% 5Y

Nasdaq, Closing price Fri, Jul 25 2025

-0.01 1.64%

ISIN

US64130M2098

Symbol

NMTC

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Key metrics

Basic

Market capitalization

$44.2m

Enterprise Value

$44.2m

Net debt

$40.0k

Cash

$1.3m

Shares outstanding

31.4m

Valuation (TTM | estimate)

P/E

negative | negative

P/S

5.0 | 5.0

EV/Sales

5.1 | 5.0

EV/FCF

negative

P/B

39.1

Financial Health

Equity Ratio

15.3%

Return on Equity

-1,498.6%

ROCE

-243.5%

ROIC

Debt/Equity

1.2

Financials (TTM | estimate)

Revenue

$8.8m | $8.9m

EBITDA

$-6.3m | $-13.6m

EBIT

$-6.6m | $-5.8m

Net Income

$-6.6m | $-4.2m

Free Cash Flow

$-5.0m

Growth (TTM | estimate)

Revenue

132.4% | 157.5%

EBITDA

50.3% | -16.6%

EBIT

49.2% | 51.4%

Net Income

48.4% | 66.2%

Free Cash Flow

59.0%

EPS

$-0.2

FCF per Share

$-0.2

Short interest

0.4%

Employees

Rev per Employee

$220.0k

As a Free StocksGuide user, you can view scores for all 7,028 stocks worldwide.

Get Started for Free Today

NeuroOne Medical Technologies Corp Stock Analysis

Unlock Scores for Free

??

7 Analysts have issued a NeuroOne Medical Technologies Corp forecast:

6x Buy

86%

More details on Analyst Estimates Including Price Targets

7 Analysts have issued a NeuroOne Medical Technologies Corp forecast:

Buy

86%

Hold

14%

Analyst Estimates with Stock Price Targets

Financial data from NeuroOne Medical Technologies Corp

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	8.76 8.76	132% 132% 100%
- Direct Costs	2.63 2.63	0% 0% 30%
Gross Profit	6.12 6.12	442% 442% 70%
- Selling and Administrative Expenses	7.71 7.71	1% 1% 88%
- Research and Development Expense	4.99 4.99	22% 22% 57%
EBITDA	-6.32 -6.32	50% 50% -72%
- Depreciation and Amortization	0.26 0.26	8% 8% 3%
EBIT (Operating Income) EBIT	-6.58 -6.58	49% 49% -75%
Net Profit	-6.61 -6.61	48% 48% -75%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

NeuroOne Medical Technologies Corp Stock News

Neutral

GlobeNewsWire

●

5 days ago

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

Patent Strengthens Intellectual Property Portfolio Surrounding Neural Probe Technologies EDEN PRAIRIE, Minn., July 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, has received a notice of all...

Neutral

GlobeNewsWire

●

about one month ago

NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

Patient Treated with OneRF ® Ablation System Previously Experienced up to 10 Seizures a Day EDEN PRAIRIE, Minn., June 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced that Clara—an e...

Neutral

GlobeNewsWire

●

about 2 months ago

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced it has strengthened its management team with the appointment of Emily Johns as General Counsel and Co...

More NeuroOne Medical Technologies Corp News

Company Profile

NeuroOne Medical Technologies Corp. operates as a medical technology company. It focuses on development and commercialization of thin film electrode technology for cEEG and sEEG recording, brain stimulation and ablation solutions for patients suffering from brain related disorders. The company was founded on August 20, 2009 and is headquartered in Eden Prairie, MN.

Head office	United States
CEO	David Rosa
Employees	16
Founded	2009
Website	nmtc1.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now